Since then, research mainly focused on addressing the CCK-2R for imaging and therapy of MTC, a cancer type for which, only limited therapeutic options (e.g., tyrosine kinase inhibitors) are available apart from surgery. The gene discussed is CCKBR; the disease is medullary thyroid gland carcinoma.